0000899243-20-018350.txt : 20200702
0000899243-20-018350.hdr.sgml : 20200702
20200702190101
ACCESSION NUMBER: 0000899243-20-018350
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200701
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paglia Regina M.
CENTRAL INDEX KEY: 0001813985
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 201011528
MAIL ADDRESS:
STREET 1: C/O DICERNA PHARMACEUTICALS, INC.
STREET 2: 33 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205993609
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 33 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-01
0
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001813985
Paglia Regina M.
C/O DICERNA PHARMACEUTICALS, INC.
33 HAYDEN AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Human Resources Officer
Restricted Stock Units
2020-07-01
4
A
0
1525
0.00
A
Common Stock
1525
1525
D
Employee Stock Option (Right to Buy)
26.62
2020-07-01
4
A
0
6825
0.00
A
2030-06-30
Common Stock
6825
6825
D
Represents restricted stock units ("RSUs") that vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of June 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer on each applicable vesting date. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock.
The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of July 2020, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the Reporting Person's continued service with the Issuer through the applicable vesting date.
/s/ Douglas W. Pagan, attorney-in-fact
2020-07-02